Cargando…

MicroRNA Profiling as Tool for In Vitro Developmental Neurotoxicity Testing: The Case of Sodium Valproate

Studying chemical disturbances during neural differentiation of murine embryonic stem cells (mESCs) has been established as an alternative in vitro testing approach for the identification of developmental neurotoxicants. miRNAs represent a class of small non-coding RNA molecules involved in the regu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Smirnova, Lena, Block, Katharina, Sittka, Alexandra, Oelgeschläger, Michael, Seiler, Andrea E. M., Luch, Andreas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4045889/ https://www.ncbi.nlm.nih.gov/pubmed/24896083 http://dx.doi.org/10.1371/journal.pone.0098892

Ejemplares similares

The Future of 3D Brain Cultures in Developmental Neurotoxicity Testing
por: Hogberg, Helena T., et al.
Publicado: (2022)

MicroRNAs in Neurotoxicity
por: Kaur, Prameet, et al.
Publicado: (2012)

Sodium Valproate Inhibits the Growth of Human Cholangiocarcinoma In Vitro and In Vivo
por: Wang, Bing, et al.
Publicado: (2013)

Wind of Change Challenges Toxicological Regulators
por: Tralau, Tewes, et al.
Publicado: (2012)

Sodium Valproate-Induced Chromatin Remodeling
por: Mello, Maria Luiza S.
Publicado: (2021)

Sodium Valproate Combined With Topiramate vs. Sodium Valproate Alone for Refractory Epilepsy: A Systematic Review and Meta-Analysis
por: Ji, Zhen-Ye, et al.
Publicado: (2022)

Developmental Neurotoxicity of Perfluorinated Chemicals Modeled in Vitro
por: Slotkin, Theodore A., et al.
Publicado: (2008)

Reproductive toxicity of sodium valproate in male rats
por: Bairy, Laxminarayana, et al.
Publicado: (2010)

Stevens - Johnson Syndrome Induced by Sodium Valproate
por: Kumar, P.N. Suresh, et al.
Publicado: (2004)

A TRIAL OF SODIUM VALPROATE IN TARDIVE-DYSKINESIA
por: Chadda, R., et al.
Publicado: (1986)

Psoriasiform Drug Eruption Associated with Sodium Valproate
por: Gul Mert, Gulen, et al.
Publicado: (2013)

Off-Label Use of Sodium Valproate for Schizophrenia
por: Horowitz, Einav, et al.
Publicado: (2014)

MicroRNAs in Methamphetamine-Induced Neurotoxicity and Addiction
por: Deng, Bi, et al.
Publicado: (2022)

Sex-Dependent Effects of the Histone Deacetylase Inhibitor, Sodium Valproate, on Reversal Learning After Developmental Arsenic Exposure
por: Tyler, Christina R. Steadman, et al.
Publicado: (2018)

Human Oligodendrocytes and Myelin In Vitro to Evaluate Developmental Neurotoxicity
por: Chesnut, Megan, et al.
Publicado: (2021)

Alternatives to animal testing: current status and future perspectives
por: Liebsch, Manfred, et al.
Publicado: (2011)

Signaling network between the dysregulated expression of microRNAs and mRNAs in propofol-induced developmental neurotoxicity in mice
por: Jiang, Congshan, et al.
Publicado: (2018)

Stevens-Johnson syndrome induced by sodium valproate monotherapy
por: Naveen, KN, et al.
Publicado: (2012)

Functional Hallucinations in Schizophrenia Responding to Adjunctive Sodium Valproate
por: Rajkumar, Ravi Philip
Publicado: (2012)

Efficacy and tolerability of injectable sodium valproate in patients with mania
por: Solanki, R. K., et al.
Publicado: (2006)

A patient with SUNCT syndrome responsive to sodium valproate
por: Meineri, Piero, et al.
Publicado: (2002)

Sodium valproate induced increased frequency of micturition and enuresis
por: Gosavi, Devesh D., et al.
Publicado: (2013)

Effect of sodium valproate on the sleep structures of epileptic patients
por: ZHANG, HUI, et al.
Publicado: (2014)

Sodium valproate compared to phenytoin in treatment of status epilepticus
por: Amiri‐Nikpour, Mohammad Reza, et al.
Publicado: (2018)

Diazepam/sodium-valproate: Lack of efficacy: case report
Publicado: (2021)

Sodium valproate prescribing safety in women of childbearing potential
por: Donnelly, Shane, et al.
Publicado: (2021)

Clozapine-associated neutropenia following augmentation with sodium valproate
por: Jakobsen, Michelle Iris, et al.
Publicado: (2021)

Levetiracetam/sodium valproate: Lack of efficacy: case report
Publicado: (2022)

Sodium valproate: cacosmia and dysgeusia as uncommon side effects
por: Montalbano, Clara, et al.
Publicado: (2023)

Comparative study of magnesium, sodium valproate, and concurrent magnesium-sodium valproate therapy in the prevention of migraine headaches: a randomized controlled double-blind trial
por: Khani, Samira, et al.
Publicado: (2021)

Altered cortical thickness following prenatal sodium valproate exposure
por: Wood, Amanda G, et al.
Publicado: (2014)

Sodium Valproate induced priapism in an adult with bipolar affective disorder
por: Bansal, Shwetank, et al.
Publicado: (2013)

The effect of sodium valproate on chronic daily headache and its subgroups
por: Yurekli, Vedat Ali, et al.
Publicado: (2008)

Sodium valproate-induced enuresis in a pediatric bipolar patient
por: Cheng, Wentao, et al.
Publicado: (2013)

Effects of Lycopene and Sodium Valproate on Pentylenetetrazol-Induced Kindling in Mice
por: Kumar, Vinay, et al.
Publicado: (2016)

Sodium Valproate Exacerbating an Underlying Disorder of Fatty Acid Metabolism
por: Bellinge, Jamie, et al.
Publicado: (2016)

Significant thrombocytopenia with sodium valproate in an adult patient with alcohol dependence
por: Goyal, Sandeep Kumar, et al.
Publicado: (2018)

Sodium Valproate Induces Cell Senescence in Human Hepatocarcinoma Cells
por: An, Hong-Mei, et al.
Publicado: (2013)

Analytical Method Development for Sodium Valproate through Chemical Derivatization
por: Abualhasan, Murad, et al.
Publicado: (2020)

Measures to Mitigate Sodium Valproate Use in Pregnant Women With Epilepsy
por: Ranjith, Saanthwana, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_fsj7gijmvverl9i3cnqg7u90d2